HAIP

What HAIP does

HAIP (Healthcare AI Platform Collaborative Innovation Partnership / 医療AIプラットフォーム技術研究組合) is a Japan-based non-profit mutual benefit research cooperative established on April 1, 2021 under the Technology Research Association Act, jointly approved by the Minister of Health, Labour and Welfare and the Minister of Economy, Trade and Industry. It originated from the Cabinet Office's SIP "AI Hospital" program and operates a three-platform medical AI infrastructure: an AI Development Platform that supports training and deployment of clinical AI, a Lab Platform for evaluation, and a Service Business Platform that curates a catalog of 40+ medical AI and digital transformation services. As of June 2026 the consortium has grown from 5–6 founding members to 21 organizations spanning AI developers (LPixel, AI Medical Service), integrators (HumaNex.AI, Cross Compass, Innomedics), and major pharmaceutical and technology partners (Suzuken, InterSystems).

The cooperative serves two interrelated customer layers. Its member organizations fund and govern the platform through dues and joint research activity, while the underlying AI/DX services are distributed to 1,000+ medical institutions across Japan via member channels and, increasingly, through Suzuken's pharmaceutical distribution network under a November 2025 basic agreement. HAIP's revenue mechanics are anchored in government grants (MHLW 23AC1001 and 23CA2044, plus SIP program funding), member contributions, and indirect commercial returns routed through AIHOBS (エーアイホープス), the commercial spin-off established April 11, 2025 with ¥6M paid-in capital to operationalize service sales. The cooperative has also extended its scope into adjacent healthcare cybersecurity with a Web Security Assessment Service launched in July 2026 and a Health ISAC Japan alliance, and has codified generative AI governance through its Generative AI Guidelines v2 issued in July 2025.

Operationally, the go-to-market is two-stage: HAIP develops and validates shared platform capabilities for the member ecosystem, while AIHOBS handles commercialization of the curated catalog. Pricing mechanics are not publicly disclosed, but the model implies a mix of platform-access fees (member-to-HAIP), service deployment contracts (AIHOBS-to-institutions), and grant-funded research activity. Leadership transitioned in April 2026 with Ugajin Atsushi assuming the chairmanship and former Chairman Hatta Yasuhide moving to lead AIHOBS, aligning governance oversight with commercial execution as the platform enters its scaling phase.

Name

HAIP

Legal name

医療AIプラットフォーム技術研究組合 (Healthcare AI Platform Collaborative Innovation Partnership)

Website

https://haip-cip.org

Company type

Private

Founded year

2021

Operating status

Operating

Short description

HAIP (Healthcare AI Platform Collaborative Innovation Partnership) is a Japan-based non-profit research cooperative operating a three-platform medical AI infrastructure for 21 member organizations and 1,000+ medical institutions, with commercial sales handled through its AIHOBS spin-off.

Ownership category

akta.pro rank

Product category

Healthcare AI Platform

NAICS

Computer Systems Design and Related Services (54151), Computer Systems Design Services (541512), Other Computer Related Services (541519), Software Publishers (5132)

SIC

Services-Computer Integrated Systems Design (7373), Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management) (HDAEANAA)

akta.pro secondary industries

AI Integration & Orchestration Platforms (Connectors, Workflow, iPaaS for AI) (HDAEANAI), AI Observability, Monitoring & Evaluation Platforms (Drift, Quality, Safety) (HDAEANAF), Responsible AI, Security & Privacy Platforms (Safety, Guardrails, PII) (HDAEANAG), Medical Imaging AI (HDAAAEAH)

Keywords

• Medical AI platform
• Healthcare AI services
• Medical DX services
• AI development infrastructure
• Healthcare data security

Headquarters

HQ city

Koto

HQ country

Japan

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Research Consortium Member Contributions: HAIP itself is a non-profit 共益法人 (mutual-benefit corporation) under the Technology Research Cooperative Law; funded by contributions and research grants (e.g., MHLW科学研究費補助金, Cabinet Office SIP program) rather than commercial revenue. Member organizations (21 as of June 2026) contribute to R&D activities.
2. AIHOBS Platform Service Fees: Commercial subsidiary AIHOBS (established April 11, 2025) operates the service business platform and sells security solutions; provides medical AI platform service infrastructure as a paid platform service to medical institutions and providers.
3. Web Security Assessment Service Fees: Paid web-based security assessment service offered in three pricing tiers (hospital IT systems / hospital management / clinic) launched July 1, 2026; positioned as low-cost, easy-to-use annual health-check style service for medical institutions.
4. Joint R&D and Licensing (Suzuken Group): Basic agreement with Suzuken Group / Collabo Square to combine Suzuken's DX platform expertise with HAIP's IP for AIHOBS security solutions and guidelines/use-cases/tools for safe utilization of generative AI in medical and long-term care settings.
5. Catalog Site (Free Access): The HAIP catalog site itself is free to browse; revenue flows when users request detailed explanations / materials and are connected to the underlying service providers, who then negotiate direct contracts (HAIP does not directly charge end-users for the catalog).

Pricing tiers

Go-to-market motion4 records

Distribution channels7 records

Marketing channels9 records

Core offering

HAIP operates an integrated Medical AI Platform comprising three bases: the AI Development Platform for medical AI modeling using real-world clinical and health-check data in secure virtual environments, the Lab Platform for third-party evaluation of medical AI by specialized reviewers from multiple medical institutions, and the Service Business Platform with a public catalog site, container-based deployment, and orchestration functions delivering multiple medical AI/DX services to medical institutions via cloud-to-cloud integration.

Product overview

HAIP (Healthcare AI Platform Collaborative Innovation Partnership / 医療AIプラットフォーム技術研究組合) is a non-profit mutual benefit corporation (技術研究組合法に基づく非営利共益法人) established on April 1, 2021 with approval from the Minister of Health, Labour and Welfare and the Minister of Economy, Trade and Industry. HAIP delivers a unified Medical AI Platform (医療AIプラットフォーム) that integrates three core platform modules: the AI Development Platform (AI開発基盤) for medical AI modeling with clinical and health checkup data in virtual environments, the Lab Platform (ラボ基盤) for third-party evaluation of AI by specialized medical professionals, and the Service Business Platform (サービス事業基盤) for catalog-based distribution, container deployment, and orchestration of medical AI/DX services. On top of this platform, HAIP operates the HAIP Catalog Site (HAIPカタログサイト) which lists 40+ partner medical AI/DX services such as EIRL (LPixel), AI-Rad Companion (Siemens), LOOKREC (Mnes), Today's Questionnaire with CDS (Precision), mediPhone (Mediphone), MVision health (M), Brain Life Imaging (Splink), kanaVo (kanata), and Reze (mutex). HAIP also publishes the Generative AI Use Guidelines for Medical/Healthcare Field (医療・ヘルスケア分野における生成AI利用ガイドライン, 1st edition Oct 2024, 2nd edition July 2025) and operates the Web Security Assessment Service (Webセキュリティアセスメントサービス, starting July 1, 2026) for medical institutions. The spinoff business company AIHOBS (株式会社AIHOBS, est. April 11, 2025) handles social implementation of the platform's service business infrastructure and security solutions. HAIP also engages in joint research on network security for cloud AI in medical settings under MHLW grant 23AC1001 and published joint recommendations with Health ISAC Japan (HIJ) on cybersecurity for generative AI in medical settings.

Differentiator

Problem solved

Functional benefit

Brands

• HAIPカタログサイト: Catalog site providing medical AI/DX service information to medical professionals (operated at catalog.haip-cip.org).
• Webセキュリティアセスメントサービス

Products and services

• Medical AI Platform (医療AIプラットフォーム) HAIP's flagship integrated platform combining three bases (AI Development Platform, Lab Platform, Service Business Platform) that provides a one-stop environment for medical AI development, evaluation, and implementation. Built on HL7 FHIR for medical data exchange and 5G-ready connectivity.
• AI Development Platform (AI開発基盤) Cloud-based platform supporting medical AI modeling and development using real-world clinical and health-screening data in a virtual environment; prevents physical data diffusion while enabling data provision to AI developers on demand. Used by Hokkaido University's CLAP program for AI developer training.
• Lab Platform (ラボ基盤) Platform for third-party evaluation of medical AI by specialized reviewers from multiple collaborating medical institutions, supporting usability and performance evaluation from the user perspective.
• Service Business Platform (サービス事業基盤) Catalog site for medical AI/DX services plus container-based deployment and orchestration functions enabling multiple AI services to be delivered to medical institutions via cloud-to-cloud integration and data orchestration.
• HAIP Catalog Site (HAIPカタログサイト) Public catalog site listing 40+ medical AI/DX services from partner companies with category filters (medical device vs. non-medical device, by modality, by clinical department, by use case); connects users to service providers.
• Web Security Assessment Service (Webセキュリティアセスメントサービス) Web-based self-check security assessment service for medical institutions with three assessment types (hospital medical information systems, hospital management, and clinic/care facility/pharmacy); outputs radar charts and detailed remediation reports built on Medical Information System Security Management Guidelines v6.0.
• AIHOBS (株式会社AIHOBS) Commercial spin-off platform that operates the medical AI platform service business infrastructure and develops/sells security solutions. Provides a secure network environment for medical institutions and care facilities to safely and easily use medical DX/AI services, connecting image AI and generative AI solution providers with medical institutions.

Quantifiable outcome

• Reduced average call time in emergency coordination from 3 min 30 sec to 2 min 44 sec at Shonan Kamakura General Hospital (TXP Medical NEXT Stage ER mobile)
• +9 more outcomes

Named customers28 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability15 records

Feature8 records

Partnerships

35 partnerships are on record, tiered minor, core and flagship.

• Innomedics Inc. (株式会社イノメディックス)minorStrategic or Co-development Partner · 9 June 2026Joined June 2026 (21st member); comprehensive medical device trading company founded 1951 with strong network of metropolitan medical institutions and expertise in medical data utilization and AI service deployment.
• Health ISAC Japan (一般社団法人 Health ISAC Japan / HIJ)coreStrategic or Co-development Partner · 7 May 2026Joint proposal (May 7, 2026) on the importance of cybersecurity measures for generative AI utilization in healthcare. Followed by formal alliance signed November 12, 2025 to jointly address cybersecurity issues in healthcare through information sharing, MHLW-funded security research, low-cost security assessment, and education.
• HumaNex.AI合同会社 (HumaNex.AI LLC)coreStrategic or Co-development Partner · 8 April 2026Joined April 2026; consulting and solutions provider leveraging global network and deep understanding of medical field for ecosystem construction, security / generative AI policy and guidelines. Hosted HAIP chairperson (Ugajin Atsushi) as representative member / CEO.
• Collabo Square Inc. (株式会社コラボスクエア)coreStrategic or Co-development Partner · 8 April 2026Joined April 2026 (20th member); part of Suzuken Group, provides digital service introductions to medical and long-term care providers; conducts R&D for cybersecurity and generative AI in medical/long-term care settings.
• Cross Compass Inc. (株式会社クロスコンパス)minorStrategic or Co-development Partner · 8 April 2026Joined April 2026 (20th member); AI/ML development platform "Greenia" provider promoting advanced AI R&D and ethical / governance frameworks for medical AI utilization.
• Suzuken Group (スズケングループ)flagshipStrategic or Co-development Partner · 13 November 2025Basic agreement signed November 13, 2025 among HAIP, AIHOBS, and Suzuken Group (via Collabo Square) to promote safe and effective utilization of generative AI in medical and long-term care. Combines Suzuken's DX platform expertise with HAIP's IP and AIHOBS's security solutions.
• Health ISAC Japan (一般社団法人 Health ISAC Japan / HIJ)coreStrategic or Co-development Partner · 12 November 2025Formal alliance signed November 12, 2025 between HIJ and HAIP to jointly address cybersecurity threats facing medical/healthcare organizations. Focus areas: information dissemination on security, MHLW-funded research, low-cost security assessment, and education/outreach.
• Medical Traceability Promotion Council (一般社団法人 医療トレーサビリティ推進協議会 / 医ト協)coreStrategic or Co-development Partner · 22 July 2025Joined July 2025; mutual membership collaboration on healthcare DX challenges (cybersecurity, talent, cost); joint operation of catalog site with 医療職のためのDXガイド; examination of traceability × AI platform integration.
• Cabinet Office SIP (Strategic Innovation Promotion Program) / 内閣府戦略的イノベーション創造プログラムflagshipOthers · 22 July 2025HAIP originated from SIP Phase 2 "AI Hospital for Advanced Diagnosis and Treatment Systems" research. Ongoing research funding / supervision relationship; many HAIP research outputs (e.g., MHLW-funded security research 23AC1001) trace back to SIP lineage.
• ZenmuTech Inc. (株式会社ZenmuTech)coreTechnology or Integration · 4 June 2025Joined June 2025 (19th member); applies secret dispersion and secret computing technologies to HAIP service platform and AI development platform for secure network solutions and AI development environment.
• AIHOBS Co., Ltd. (株式会社AIHOBS)flagshipOEM/ Whitelabel/ Licensing Partner · 11 April 2025Commercial spin-off established April 11, 2025 by HAIP via incorporation-type separation (新設分割), approved by both Ministry of Health, Labour and Welfare and Ministry of Economy, Trade and Industry. AIHOBS operates the medical AI platform service business infrastructure and sells security solutions; chaired by Hatta Yasuhide. Capital 600万円. Later joined HAIP as a member on 2025-06-04 (becoming 19th member).
• Quest Global Japan (クエスト・グローバル・ジャパン株式会社)minorImplementation/ SI/ Consulting Partner · 1 April 2025Joined April 2025 (17th member); Japan arm of Quest Global Services (Singapore, 20,000+ engineers across 20+ countries) providing engineering services for AI development platform, lab platform, and service platform integration and maintenance.
• Southwood Co., Ltd. (株式会社サウスウッド)minorStrategic or Co-development Partner · 11 October 2024Joined October 2024 (18th member); ultrasound-domain SaMD startup developing portable echo with edge AI + cloud AI to support telemedicine / home care.
• J's Technology Co., Ltd. (ジェイズ・テクノロジー株式会社)coreStrategic or Co-development Partner · 24 May 2024Joined May 2024 (17th member); provides secure network solutions and IT security talent development support for medical institutions.
• Segue Group Inc. (セグエグループ株式会社)coreStrategic or Co-development Partner · 2 April 2024Joined April 2024 (became 16th member); security / network / data-protection specialist providing logical separation, secret dispersion, and secure computation solutions for medical AI utilization.
• Juntendo (学校法人 順天堂)coreStrategic or Co-development Partner · 6 July 2023Joined July 2023; brings 7 faculties / 6 affiliated hospitals including Juntendo University Hospital for medical AI needs identification, digital therapeutics, and clinical use case generalization.
• LifeQuest Inc. (株式会社ライフクエスト)minorStrategic or Co-development Partner · 6 July 2023Joined July 2023; SaMD / non-medical device program R&D startup with proprietary 行動変容エンジン® (behavior change engine) addressing digital health market growth challenges.
• Roche Diagnostics Japan (ロシュ・ダイアグノスティックス株式会社)coreStrategic or Co-development Partner · 11 November 2022Joined October 2022; brings world-class biotech diagnostics expertise to accelerate medical AI dissemination using HAIP development and lab platforms.
• ALBERT Inc. (株式会社ALBERT)minorStrategic or Co-development Partner · 26 August 2022Joined August 2022; data analytics and AI implementation specialist contributing big data / AI expertise and medical AI talent development support.
• National Center for Global Health and Medicine (国立国際医療研究センター)coreStrategic or Co-development Partner · 5 August 2022Joined August 2022; conducts image diagnosis AI R&D (liver cancer etc.) on HAIP AI Development Platform and HL7 FHIR-based EMR integration research.
• Hokkaido University (国立大学法人北海道大学)coreStrategic or Co-development Partner · 26 April 2022Joined April 2022; runs the CLAP (Clinical AI Human Resources Development Program) using HAIP's AI Development Platform for hands-on training; co-researcher on cloud AI security; regulatory science collaboration.
• National Center for Child Health and Development (国立成育医療研究センター)coreStrategic or Co-development Partner · 12 January 2022Joined January 2022; key research partner for AI development platform validation, Gram-stain AI, and MHLW cloud AI security research (23AC1001). Director Umezawa Akihiro.
• InterSystems Japan (インターシステムズジャパン株式会社)coreTechnology or Integration · 12 January 2022Joined January 2022; brings HL7 FHIR expertise and implementation experience to enable diverse applications and data interoperability with the medical AI platform. Also awards HAIP the Impact Award 2024.
• Japan Medical Association AI Hospital Promotion Center (JMAC-AI / 日本医師会AIホスピタル推進センター)flagshipStrategic or Co-development Partner · 11 August 2021Strategic collaboration since the HAIP platform trial operation (Phase 1 in August 2021). JMAC-AI registers and recruits participating physicians, evaluates business processes, and plans to certify AI Hospital system platform providers in the future. Joint operation of trial services including EIRL Brain Aneurysm, LOOKREC, 今日の問診票 with CDS, and Antaa QA.
• Mnes Inc. (株式会社エムネス)coreTechnology or Integration · 11 August 2021Joint trial operation partner (2021-08-11 onward) integrating LOOKREC cloud DICOM viewer with the HAIP platform for the first-phase trial use of EIRL Brain Aneurysm; ongoing technology partner.
• LPixel Inc. (エルピクセル株式会社)coreTechnology or Integration · 11 August 2021Joint trial operation partner (2021-08-11) providing EIRL Brain Aneurysm for HAIP platform Phase 1 trial; multiple EIRL products are listed on the HAIP catalog.
• Taiju Life Insurance (大樹生命保険株式会社)minorStrategic or Co-development Partner · 30 June 2021Joined as 6th member in June 2021 to broaden insurance / healthcare ecosystem engagement.
• Tokushukai Information System Co., Ltd. (徳洲会インフォメーションシステム株式会社)coreStrategic or Co-development Partner · 30 June 2021Joined June 2021; brings large hospital group (Tokushukai) IT operational expertise, security audit know-how, and serves as Director (Ozaki Katsuhiko).
• Microsoft Japan (日本マイクロソフト株式会社)coreTechnology or Integration · 30 June 2021Joined June 2021; provides Azure / cloud / AI platform technology for medical AI infrastructure; Director Sato Ryota.
• BIPROGY Co., Ltd. (formerly Nihon Unisys)flagshipStrategic or Co-development Partner · 1 April 2021Founding member (originally as Nihon Unisys) and host of the HAIP chairperson (Yasuhide Hatta, also BIPROGY Executive Strategic Advisor). Provides core IT platform / system integration capabilities and serves as a foundational pillar of the consortium.
• Hitachi High-Tech (formerly Hitachi)flagshipStrategic or Co-development Partner · 1 April 2021Founding member; provides hardware / measurement / IT infrastructure expertise. Hosts the HAIP managing director (Ugajin Atsushi as Chief Engineer at Hitachi High-Tech).
• IBM JapanflagshipStrategic or Co-development Partner · 1 April 2021Founding member providing AI / cloud / enterprise technology expertise (represented by Director Kaneko Tatsuya).
• SoftBank Corp.flagshipStrategic or Co-development Partner · 1 April 2021Founding member providing telecom / network / 5G capabilities (Director Fujinaga Kunihiro / NakaTsuka Hiroyasu).
• Mitsui & Co.flagshipStrategic or Co-development Partner · 1 April 2021Founding member providing business / commercialization expertise.
• Ministry of Health, Labour and Welfare (厚生労働省) and Ministry of Economy, Trade and Industry (経済産業省)flagshipOthers · 1 April 2021HAIP operates under approval and ongoing oversight from both ministries per the Technology Research Cooperative Law. MHLW also funds related research (e.g., 23AC1001 cloud AI network security, 23CA2044 generative AI guideline). Related organizations: 国立健康危機管理研究機構 (Japan Institute for Health Security), 国立医薬基盤・健康・栄養研究所, 内閣府.

Scale indicators12 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Fujifilm Medical: Fujifilm is a major Japanese medical imaging incumbent whose CXR-AID, lung nodule detection, and SYNAPSE VINCENT products are listed on HAIP's catalog. It is a broad incumbent comparable to HAIP because both provide regulated diagnostic imaging AI to Japanese hospitals, with Fujifilm offering a vertically integrated hardware + software + AI stack while HAIP offers an open platform.
• Siemens Healthineers: Siemens is a HAIP member whose AI-Rad Companion and syngo.via suite are listed on HAIP's catalog. As a broad incumbent, Siemens sells its own hospital imaging AI platform globally; it overlaps with HAIP in offering regulated diagnostic AI to Japanese medical institutions, while also competing with HAIP's orchestration layer by offering its own integrated platform.
• Tempus AI: Tempus is a broad incumbent in the medical AI/data platform space, with multi-omics data, AI applications, and a marketplace. Comparable to HAIP because both aggregate medical AI services and data, but Tempus is a large for-profit public company with much broader commercial reach and a US-centric footprint.

Regional players

• MICIN Inc. MICIN is a Japan-focused digital health company offering telemedicine, online medical care, and AI-driven clinical workflow tools. It is a regional peer because it targets the same Japanese medical institutions and provider workflows (telehealth, e-consent, AI documentation) as several catalog services on HAIP, competing for similar hospital IT budget in Japan.

Emerging players

• Arterys: Arterys is a medical imaging AI platform that hosts third-party AI algorithms in a cloud marketplace (now part of Tempus's ecosystem). It is an emerging peer to HAIP because both pursue a cloud-based AI marketplace / orchestration model for hospital imaging AI, with overlapping technology stack (cloud-native, FHIR/DICOM integration, app marketplace).

Direct peers

• Aidoc Medical: Aidoc is a global medical imaging AI platform that orchestrates multiple AI algorithms (worklist prioritization, triage, detection) inside hospital workflows. It is a direct peer to HAIP's Service Business Platform because both pursue an AI-orchestration platform strategy serving radiologists and hospital IT, though Aidoc's commercial footprint is largely US/EU.
• LPixel Inc. LPixel is a HAIP member whose EIRL series of medical imaging AI products (Brain Aneurysm, Chest CT, Brain Metry, etc.) is the most-catalogued service on HAIP. Both target the same Japanese medical institutions with AI-powered diagnostic imaging, and LPixel competes/collaborates with HAIP on the same hospital procurement budgets.
• Viz.ai: Viz.ai operates a healthcare AI coordination platform (most notably for stroke triage) that integrates imaging AI into clinical workflows. It is a direct peer because both target the same healthcare-AI-platform category — embedding regulated AI services into hospital IT and providing a marketplace/orchestration layer for multiple AI applications.
• AI Medical Service Inc. Japan-based medical AI vendor specializing in endoscopy AI (gastrointestinal lesion detection). It is a direct peer because it offers regulated SaMD imaging AI to Japanese hospitals via PMDA approvals, addressing the same clinical AI use cases and competing for similar hospital IT budget as the imaging AI services hosted on HAIP's catalog.
• InterSystems: InterSystems is a HAIP member and the technology partner that provides HL7 FHIR infrastructure underpinning the HAIP platform. It is a direct peer because both operate healthcare data interoperability and AI application enablement platforms serving medical institutions and AI service providers, with overlapping technology stacks (FHIR, IRIS for Health).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/HAIP_official

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HAIP